We investigated the mechanisms responsible for the widespread refractoriness to
chemotherapeutic drugs observed in thyroid cancers. We show that malignant epithelial …

PURPOSE: To retrospectively analyze the outcome of patients with anaplastic thyroid
carcinoma (ATC) treated in the Erasmus MC. MATERIAL AND METHODS: Seventy-five ATC …

Thyroid cancer is an uncommon malignancy that accounts for roughly 1% of all new
cancers. Although anaplastic lesions constitute fewer than 5% of thyroid cancers, they …

Background The aim of the present study was to investigate the role of a multimodality
treatment for anaplastic thyroid carcinoma (ATC). Methods Clinical data of 40 consecutive …

Current chemotherapy with doxorubicin fails to eradicate anaplastic thyroid cancer or even
to stop tumor progress which may be due to the failure of these drugs to effectively target …

BACKGROUND The outcomes of patients with unresected anaplastic thyroid carcinoma
(ATC) from the National Cancer Data Base (NCDB) were assessed, and potential …

Background To review the current literature on the treatment of anaplastic thyroid cancer
(ATC) and thyroid lymphoma (TL). Results Both anaplastic carcinoma (ATC) and TL …

BACKGROUND Because anaplastic thyroid cancer is a rare malignancy with a high
mortality rate, the benefit of multimodality treatment was evaluated. METHODS Overall …

Anaplastic thyroid carcinomas (ATCs) are highly aggressive, extremely lethal human
cancers with poor therapeutic response. Chemokines are a superfamily of small cytokine …

Background: This study aimed to analyze the temporal changes of the clinicopathologic
characteristics, and the long-term outcomes, of various types of anaplastic thyroid cancer …